


SOCS3
Anti-SOCS3 Recombinant Antibody Products
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG2b, κ
- Application: WB, IP, ELISA
-
- Species Reactivity: Human
- Type: Mouse antibody
- Application: ELISA, IHC-P, WB
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: WB, ELISA, IHC
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: WB, ELISA
- Mouse Anti-SOCS3 Recombinant Antibody (clone 3A10A12) (VS7-0425-WR902)
-
- Species Reactivity: Human
- Type: Mouse IgG1
- Application: WB, IHC, ICC, FC
- Mouse Anti-SOCS3 Recombinant Antibody (clone 5E12E7F1) (VS7-0425-WR903)
-
- Species Reactivity: Human
- Type: Mouse IgG1
- Application: IHC, ICC, FC
- Mouse Anti-SOCS3 Recombinant Antibody (VS7-0425-WR904) (VS7-0425-WR904)
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: WB, IHC-P, IF
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Disease related genes
Intracellular
Cell type enhanced (Adipocytes, Endothelial cells, Skeletal myocytes, Fibroblasts, Smooth muscle cells, Langerhans cells)
Immune cell enhanced (neutrophil)
Cell line enhanced (HDLM-2, HSkMC, U-266/70)
Interacts with multiple activated proteins of the tyrosine kinase signaling pathway including IGF1 receptor, insulin receptor and JAK2. Binding to JAK2 is mediated through the KIR and SH2 domains to a phosphorylated tyrosine residue within the JAK2 JH1 domain (PubMed:10421843). Binds specific activated tyrosine residues of the leptin, EPO, IL12, GSCF and gp130 receptors (PubMed:12027890, PubMed:14559241). Interaction with CSNK1E stabilizes SOCS3 protein (PubMed:15070676). Component of the probable ECS(SOCS3) E3 ubiquitin-protein ligase complex which contains CUL5, RNF7/RBX2, Elongin BC complex and SOCS3 (PubMed:15601820). Interacts with CUL5, RNF7, ELOB and ELOC (PubMed:15601820). Interacts with CUL2 (PubMed:15601820). Interacts with FGFR3 (PubMed:16410555). Interacts with INSR (By similarity). Interacts with BCL10; this interaction may interfere with BCL10-binding with PELI2 (By similarity). Interacts with NOD2 (via CARD domain); the interaction promotes NOD2 degradation (PubMed:23019338).
Signal transduction inhibitor